Ascendis Pharma A/S (ASND) CEO Jan Mikkelsen on Q1 2022 Resu

Ascendis Pharma A/S (ASND) CEO Jan Mikkelsen on Q1 2022 Results - Earnings Call Transcript

Ascendis Pharma A/S (ASND) CEO Jan Mikkelsen on Q1 2022 Results - Earnings Call Transcript

seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Japan , China , Shanghai , United States , Ukraine , America , Jan Mikkelsen , Ascendis Pharma , Leland Gershell , Jessica Fye , Dana Pizzuti , Vikram Purohit , Juha Punnonen , Josh Schimmer , Lonapegsomatropin Ascendis Pharma , Tim Lee , David Lebowitz , Scottt Smith , Josephp Schwartz , Timothyj Lee , Las Vegas , Scott Smith , Stina Singel , Joseph Schwartz , Morgan Stanley , Company Participants , Transcon Technology Platform , Head Of Development Operations , European Commission , Oppenheimer Co , Head Of Clinical Development Oncology , Head Of Clinical Development , European Union , Conference Call May , Chief Executive , Senior Vice President , Chief Financial , Senior Director , Development Operations , Chief Medical , Clinical Development , First Quarter , Pharma Earnings Conference , Senior Director Investor , Investor Relations , Chief Executive Officer , Chief Financial Officer , Chief Medical Officer , Safe Harbor , Private Securities Litigation Reform , Risk Factors , Con Human Growth Hormone , North America , Transcon Technology , Transcon Growth Hormone , Eastern European , Transcon Human Growth Hormone , Japan Phase , Hour Calcium , East European ,